Variations in worker compensation claims by company: the potential for achieving a significant reduction in claims.

Variations in worker compensation claims by company: the potential for achieving a significant reduction in claims. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Variations in worker compensation claims by company: the potential for achieving a significant reduction in claims. Abstract Text:

Kenneth D Rosenman,Alice Kalush,Mary Jo Reilly,

BACKGROUND: The objective of our study was to examine the potential reduction in paid worker compensation claims if the rate of claims were as low as the rates of the top companies in that industry category. METHODS: Using Michigan data for the years 1999-2001, we first excluded companies who had no paid worker compensation claims for wage replacement and then calculated the top 10th, 25th, and 50th percentile rates of paid worker compensation claims for wage replacement of all the remaining companies combined and by 2 digit SIC. The percent reduction was calculated separately for small (<20 employees) and large companies based on the differences in observed minus expected if all companies did as well as the top companies in their industry grouping. RESULTS: Fifty-nine percent of large companies and 90% of small companies had no paid worker compensation claims for wage replacement over the 3-year period. Controlling for industry type there would have been 91,504 fewer paid workers' compensation claims if all companies with at least one claim did as well as the 10th percentile or better as the companies in their industry grouping. Reductions were found across all industries and for both small and large companies. CONCLUSION: Variations in worker compensation claims between states are highlighted when legislators consider "reforms" to reduce workers' compensation costs. These reforms overlook the larger variation between companies within the same type of industry in the same state. Possible reasons for this variation between companies and its implication on reducing morbidity and health care costs are discussed.

Variations in worker compensation claims by company: the potential for achieving a significant reduction in claims. Publishing Authors By Initials

KD Rosenman,A Kalush,MJ Reilly,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Variations in worker compensation claims by company: the potential for achieving a significant reduction in claims. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: American journal of industrial medicine

VOLUME: 50

Page Numbers: 415-20

Journal Abbreviation: Am. J. Ind. Med.

ISSN: 0271-3586

DAY: 3

MONTH: Jun

YEAR: 2007

Variations in worker compensation claims by company: the potential for achieving a significant reduction in claims. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8101110

Variations in worker compensation claims by company: the potential for achieving a significant reduction in claims. Keywords Mesh Terms:

KEYWORDS: Workers' Compensation

MESH TERMS: utilization

Chemical & Substance for Abstract: Variations in worker compensation claims by company: the potential for achieving a significant reduction in claims. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Variations in worker compensation claims by company: the potential for achieving a significant reduction in claims.

AFFILIATION: Michigan State University, East Lansing, MI 48824, USA. rosenman@msu.edu

Country: United States

AGENCY: United States NIOSH

GRANT: 5 R01 OH004276

ACRONYM: OH

MEDLINETA: Am J Ind Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Variations in worker compensation claims by company: the potential for achieving a significant reduction in claims Related Publications

• A top-down/bottom-up study of the ribosomal proteins of Caulobacter crescentus.
• Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.
• Automated docking to explore subsite binding by glycoside hydrolase family 6 cellobiohydrolases and endoglucanases.
• Brain event-related potentials: diagnosing early-stage Alzheimer's disease.
• C-fos expression in the rat brain following lithium chloride-induced illness.
• Can Visual Evoked Potentials be used in Biometric Identification?
• Caring for obese pregnant women.
• Disclosing conflicts of interest in biomedical research.
• Effects of central and basolateral amygdala lesions on conditioned taste aversion and latent inhibition.
• Effects of lesions of the bed nucleus of the stria terminalis, lateral hypothalamus, or insular cortex on conditioned taste aversion and conditioned odor aversion.
• Frequency of Abnormal Scores on the Neuropsychological Assessment Battery Screening Module (S-NAB) in a Mixed Neurological Sample.
• Future perspectives in the evaluation of the physiological demands of soccer.
• Gene structure, expression profiling and mutation analysis of the tumour suppressor SHIP1 in Caucasian acute myeloid leukaemia.
• How patients with depressive symptoms view their condition: a qualitative study.
• Implications of the consensus definition of clinical resistance and intolerance to hydroxyurea for clinical practice.
• Introduction to Chronobiology: 471: 9:05 AM-9:30 AM.
• Laser-induced photofragmentation of neutral and acidic glycans inside an ion-trap mass spectrometer.
• NMDA receptor antagonist MK-801 infused into the insular cortex prevents the attenuation of gustatory neophobia in rats.
• Neural mass model of human multisensory integration.
• Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.
• Practical approach to treating essential thrombocythaemia: case studies.
• Recurrent haemorrhage from a malignant brain stem glioma: a review of the mechanisms of tumoural haemorrhage.
• Ruminal fermentation of propylene glycol and glycerol.
• Safety Assessment of Genetically Modified (GM) Foods.
• Sources of graft restriction after single lung transplantation for emphysema.
• Still leader of the pack. Intermountain tops ranking of integrated networks.
• The use of light-emitting diode therapy in the treatment of photoaged skin.
• Transient receptor potential vanilloid 1 agonists cause endoplasmic reticulum stress and cell death in human lung cells.
• Variability in the diagnosis and point selection for persons with frequent headache by traditional Chinese medicine acupuncturists.
• Variations in worker compensation claims by company: the potential for achieving a significant reduction in claims.